Dimensional Fund Advisors LP
- SEC CIK
- 0000354204
- Latest filing
- Aug 11, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 694,743
- Value
- $10.1M
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 694,743 | $10.1M | <0.1% | +262,903+60.9% | Added | Holders |
| Q1 2026 | 431,840 | $4.59M | <0.1% | +133,919+45.0% | Added | Holders |
| Q4 2025 | 297,921 | $2.80M | <0.1% | +18,104+6.5% | Added | Holders |
| Q3 2025 | 279,817 | $2.11M | <0.1% | −33,546−10.7% | Reduced | Holders |
| Q2 2025 | 313,363 | $1.06M | <0.1% | +24,761+8.6% | Added | Holders |
| Q1 2025 | 288,602 | $1.11M | <0.1% | +73,337+34.1% | Added | Holders |
| Q4 2024 | 215,265 | $1.33M | <0.1% | +80,905+60.2% | Added | Holders |
| Q3 2024 | 134,360 | $722.8K | <0.1% | +53,407+66.0% | Added | Holders |
| Q2 2024 | 80,953 | $271.2K | <0.1% | +44,098+119.7% | Added | Holders |
| Q1 2024 | 36,855 | $148.5K | <0.1% | −4,993−11.9% | Reduced | Holders |
| Q4 2023 | 41,848 | $111.1K | <0.1% | −12,267−22.7% | Reduced | Holders |
| Q3 2023 | 54,115 | $127.8K | <0.1% | −5,520−9.3% | Reduced | Holders |
| Q2 2023 | 59,635 | $374.9K | <0.1% | −16,850−22.0% | Reduced | Holders |
| Q1 2023 | 76,485 | $441.2K | <0.1% | −77,635−50.4% | Reduced | Holders |
| Q4 2022 | 154,120 | $1.58M | <0.1% | +25,248+19.6% | Added | Holders |
| Q3 2022 | 128,872 | $2.16M | <0.1% | +100,728+357.9% | Added | Holders |
| Q2 2022 | 28,144 | $394.0K | <0.1% | +28,144 | New | Holders |